Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.

AIDS (London, England) - 13 Mar 2010

Gatanaga Hiroyuki, Ode Hirotaka, Hachiya Atsuko, Hayashida Tsunefusa, Sato Hironori, Takiguchi Masafumi, Oka Shinichi

Abstract excerpt

OBJECTIVE: The objective of this study is to determine the impact of human leukocyte antigen (HLA)-B*51-restricted cytotoxic T-lymphocyte (CTL) pressure on the development of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance. DESIGN: The prevalence of HIV-1 harboring an escape muta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to HIV Infections
Share to HLA-B Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Evasion

Share to Immunodominant Epitopes

Share to Reverse Transcriptase Inhibitors

Share to T-Lymphocytes, Cytotoxic

Share to Viral Load

Source

Identifiers

PMID: 20160632
DOI: 10.1097/QAD.0b013e328337b010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20160632-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance.PMID 20160632Read ↗

Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.Semantic proximity Read ↗

Characterization and Structural Analysis of Novel Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involved in the Regulation of Resistance to Nonnucleoside InhibitorsSemantic proximity Read ↗

Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.Semantic proximity Read ↗

Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.Semantic proximity Read ↗

Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.Semantic proximity Read ↗

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.Semantic proximity Read ↗

Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population.Semantic proximity Read ↗

Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1.Semantic proximity Read ↗

Virus variation, escape from cytotoxic T lymphocytes and human retroviral persistence.Semantic proximity Read ↗

Substitutions at Amino Acid Positions 143, 148, and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance <i>In Vivo</i>Semantic proximity Read ↗

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline.Semantic proximity Read ↗

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.